Amber Therapeutics develops the next-generation of bioelectrical therapies.
Amber Therapeutics's investors include 8VC, New Enterprise Associates, Oxford Science Enterprises, F-Prime, Lightstone Ventures.
Amber Therapeutics is headquartered in London, United Kingdom.
Amber Therapeutics develops the next-generation of bioelectrical therapies.
Amber Therapeutics is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amber Therapeutics — Funding & Investors." VCBacked, March 19, 2026, https://www.vcbacked.co/company/amber-therapeutics. Accessed July 19, 2026.
VCBacked. (2026). Amber Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/amber-therapeutics
{{cite web |title=Amber Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amber-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated